HUAPONT PHARM.
PRODUCTS & SERVICE
Anastrozole Tablets
Category：
English Name：
Anastrozole Tablets
Strength:
1mg
Package：
Aluminum-plastic blister; 14 tablets/blister/box
Approval Number：
H20020194
Detail
Indications:
Reference Listed Drug during bioequivalence study of this medication is ARIMIDEX® by Astrazeneca.
This product is indicated for:
Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer
Treatment of advanced breast cancer in postmenopausal women. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to this product.
Adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women who have received tamoxifen therapy for 2 to 3 years.
Other information such as dosage, contraindications, and adverse reactions is detailed in the instructions.
Previous
Next
Previous
Next
Other Products
I Want to Consult
Hi!
Thank you for visiting Huapont Pharma's official website, if you have any cooperation intentions or suggestions, please contact us through the following ways, we will contact with you as soon as possible, thank you!
Address: No. 69, Xingguang Avenue, Renhe Town, Yubei District, Chongqing, 401121, China.
Code: 401121
Email: service@huapont.cn
© 2024 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved. 
渝公网安备 50019002503004号